Related by context. All words. (Click for frequent words.) 66 Japanese Encephalitis Vaccine 65 Prodarsan R 65 immuno therapeutic 65 Japanese Encephalitis vaccine 65 oncolytic virus therapies 65 ChimeriVax JE 64 nasal powder 64 Alferon N 64 Enhanze 64 EV# vaccine 64 BrachySil TM 64 recombinant hepatitis B 64 nasally delivered 64 HEPLISAV TM hepatitis B 64 ZFP Therapeutics 64 intranasal insulin product 63 valent pneumococcal conjugate vaccine 63 SYCREST 63 MOVIPREP R 63 acyclovir Lauriad R 63 H#N# VLP vaccine 63 Bioral Amphotericin B 63 Vaxfectin ® 63 novel therapeutic antibodies 63 cGMP manufacture 63 GVAX ® 63 IIa clinical trials 63 investigational hepatitis B 62 StaphVAX R 62 therapeutic monoclonal antibody 62 conjugate vaccines 62 Respiratory Syncytial Virus RSV 62 GRNVAC1 62 immunotherapeutic vaccine 62 trivalent seasonal influenza 62 MMR Measles Mumps Rubella 62 SynCon 62 Phase 2a clinical trials 62 Intercell Japanese Encephalitis 62 using Crucell PER.C6 62 FluINsure 62 VLP vaccine candidate 61 IMA# 61 vaccine Synflorix 61 Surfaxin LS 61 Pentavalent 61 pneumococcal conjugated vaccine 61 tetravalent dengue vaccine 61 Bayer HealthCare Onyx Pharmaceuticals 61 ETEC vaccine 61 Evoltra ® 61 recombinant biopharmaceutical 61 Intercell vaccine 61 serogroup B 61 RiVax 61 Hepavax Gene ® 61 MVA#A 61 GelVac TM 61 methylnaltrexone bromide 61 Cand5 61 HepaGam B 61 Pandemic Influenza Vaccine 61 PREVENAR 61 AdVac R 61 dose intramuscular 61 AdVac ® 61 IXIARO 61 thetreatment 61 Panflu 61 rxRNA 61 pentavalent 61 Twinrix 60 MKC# MT 60 Adjuvanted 60 Civacir 60 CMV vaccine 60 forodesine 60 fully liquid pentavalent 60 Shigamabs 60 SparVax ™ 60 Synflorix 60 oral rotavirus vaccine 60 IIa trials 60 TELINTRA R 60 initiated Phase Ib 60 ospemifene 60 torezolid phosphate 60 Hepavax Gene 60 TransVax tm 60 AERAS-#/Crucell Ad# 60 MenB 60 biodefense vaccines 60 commercialize ZYFLO CR 60 R#/MEM # 60 Zemplar Capsules 60 CPL Biologicals 60 Sanofi Pasteur Fluzone 60 Phase III ADT 60 hepatitis B immune globulin 60 MVA BN ® 60 Soliris eculizumab 60 oral PTH 60 vaccine Menveo 60 Phase Ib II 60 recombinant influenza 60 vaccine LAIV 60 Phase #b/#a clinical 60 PANVAC VF 60 VIRUSMAX TM 59 proprietary intranasal insulin 59 Bilive TM 59 Inovocox TM 59 quadrivalent HPV vaccine 59 BioDelivery Sciences Announces 59 Menjugate 59 plasmid DNA pDNA 59 Imvamune R 59 CRMD# 59 generation purine nucleoside 59 DepoVax TM 59 Fluviral 59 multicenter Phase II 59 kidney urologic 59 PRNewswire Sinovac Biotech 59 Varicella vaccine 59 Staphylococcus aureus Polysaccharide Conjugate 59 AdhTAP 59 ROTATEQ 59 IMVAMUNE TM 59 PREVNAR 59 AERx ® 59 trivalent influenza vaccine 59 PrevOnco ™ 59 Potelligent Technology 59 Tarvacin Anti Cancer 59 molecular chaperone regulation 59 Crofelemer budesonide foam 59 GelVac 59 recombinant vaccines 59 EndoBiologics 59 GTC recombinant human 59 HuMax TAC 59 subunit vaccine 59 attenuated smallpox vaccine 59 IMVAMUNE 59 Testosterone MDTS ® 59 Modified Vaccinia Ankara MVA 59 OncoGel 59 commercialize deforolimus 59 biotherapeutic drugs 59 initiate Phase 2b 59 endothelin antagonist 59 StemEx R 59 GelSite 59 Stimuvax R 59 Inotek Pharmaceuticals Corporation 59 H#N# monovalent vaccine 59 Adnectin 59 Xcellerex FlexFactory 59 bavituximab monotherapy trial 59 Cumulase 59 Protexia ® 59 CERVARIX 59 Fodosine 59 IXIARO ® 59 inhaled AAT 58 TNFerade ™ 58 conjugate vaccine 58 trivalent seasonal flu 58 injectable influenza 58 Harry Palmin President 58 anti infective treatments 58 molecular therapeutics immunotherapies 58 Phase III multicenter 58 patented DepoVax TM 58 recombinant vaccine 58 telomerase therapeutic 58 Shigamabs ® 58 antigen rPA anthrax 58 ABthrax TM raxibacumab 58 adecatumumab MT# 58 recombinant polyclonal antibodies 58 rPA anthrax vaccine 58 tetravalent 58 NYSE Amex SVA 58 Initiate Phase 58 NP2 Enkephalin 58 Loramyc TM 58 oral methylnaltrexone 58 CELVAPAN H#N# 58 MenACWY 58 SinuNase ™ 58 phase IIb III 58 synDNA TM 58 synthetic peptide containing 58 VLP vaccine 58 H#N# Influenza Vaccine 58 Archexin 58 ROTARIX 58 Phase lll 58 Altastaph 58 Dermylex TM 58 OvaRex ® MAb 58 Alferon N Injection 58 ATG Fresenius S 58 multicenter dose escalation 58 Lovaza TM 58 Exherin TM 58 APEX PD 58 XOMA 3AB 58 Phase 1a clinical 58 RECOTHROM ® 58 Multimeric 58 Selective Electrochemical Tumor Ablation 58 LEAPS TM 58 IIa clinical 58 Panenza 58 synthetic surfactant 58 lipopeptide 58 Alferon LDO 58 Novartis MenB vaccine 58 Imvamune 58 Chimigen 58 influenza VLP vaccine 58 pertussis tetanus 58 non nucleoside HCV 58 Hiberix 58 ulimorelin 58 staphylococcal vaccine 58 vaccine Fluarix 58 PDE4 inhibitor 58 IND submission 57 tolevamer 57 HepB 57 TBC# 57 ONCONASE R 57 Varicella chicken pox 57 pentavalent rotavirus vaccine 57 Phase IIA 57 alvespimycin 57 ALN VSP Phase 57 Ceragenin ™ 57 Submits Response 57 initiate multicenter 57 Inactivated 57 intranasal influenza 57 Vivotif ® 57 using VIAdel TM 57 Phase Ib IIa 57 Toxoid 57 virology immunology 57 highly immunogenic 57 Ganciclovir 57 tramiprosate Alzhemed TM 57 genetically engineered recombinant protein 57 systemic RNAi 57 Vaccine Live Intranasal 57 delivery polymer matrix 57 Foradil Aerolizer 57 include Altastaph TM 57 anticoagulant reversing agent 57 adenovirus serotype 57 Pentacel R 57 Tyzeka Sebivo 57 SNT MC# 57 phase Ib clinical 57 meningococcal serogroup B 57 leading oral taxane 57 smallpox vaccine Imvamune 57 Phase 1b trial 57 GelSite R 57 treatmentof 57 Allovectin 7 57 Tamiflu oseltamivir phosphate 57 Phase IIb clinical trials 57 GARDASIL ® 57 bioREV 57 HCV RNA polymerase 57 Allovectin 7 r 57 GelSite R polymer 57 PepTcell 57 QNEXA ® 57 SparVax 57 Prodarsan 57 Shigamabs R 57 generation URAT1 inhibitor 57 gastro intestinal inflammation 57 RapidResponse TM DNA 57 OvaRex R 57 delta opioid receptor 57 nalbuphine ER 57 Glassia 57 diptheria tetanus 57 Spiegelmer ® 57 Beike stem cell 57 KINRIX 57 EVIZON TM squalamine lactate 57 Ltd. Amex SVA 57 include Alferon N 57 cathepsin K inhibitor 57 albiglutide 57 Diamyd R 57 initiate Phase IIa 57 IMVAMUNE ® 57 oral NKTR 57 Rotarix R 57 including eniluracil ADH 57 Quinvaxem R 57 Menactra vaccine 57 AFFITOME R 57 TaiGen 57 vaccine Pandemrix 57 ZADAXIN ® 57 tetravalent vaccine 57 Merck RotaTeq 57 recombinant protective 57 Anflu R 57 quadrivalent meningococcal conjugate vaccine 57 Humenza 57 Phase #/#a 57 SEPET TM 57 Cerashield ™ 57 H#N# antigen 57 Bioniche E. coli 57 BioThrax Anthrax Vaccine Adsorbed 57 anthrax monoclonal antibody 57 Nascobal ® 57 Nascobal R 57 inactivated influenza vaccine 57 recombinant subunit vaccine 57 include Healive 57 ACIP recommended 57 Phase #b/#a 57 TP# CETi 1 56 recombinant PSMA vaccine 56 Human cl 56 GLP toxicology studies 56 rhMBL 56 Captisol ® 56 7 valent Conjugate 56 phase IIb study 56 rhLF 56 anti CD3 monoclonal 56 LC#m# 56 Acetavance TM intravenous acetaminophen 56 FLU v 56 ® bortezomib 56 deforolimus 56 neurology immunology 56 Rotarix ® 56 FLUPAN 56 Vaxfectin 56 Telatinib 56 pneumococcal conjugate 56 omacetaxine mepesuccinate 56 Sebivo 56 Phase III confirmatory 56 trivalent inactivated vaccine 56 Prodarsan ® 56 sterile injectable 56 BioVant 56 Pentacel vaccine 56 Myozyme ® alglucosidase 56 Shigatoxin producing E. coli 56 R Influenza Virus 56 Somatuline R Autogel R 56 Bacterin develops manufactures 56 IV APAP 56 DepoCyt 56 Elan NanoCrystal 56 GlaxoSmithKline Rotarix 56 phase IIa clinical 56 Diamyd ® 56 oral taxane 56 A/H#N# vaccine 56 MVA BN 56 generation PNP inhibitor 56 DosePro TM 56 Isis antisense 56 dietary supplement formulated 56 vaccine Rotarix 56 measles mumps rubella varicella 56 immunodiagnostic 56 candidate REP# 56 Phase III Pivotal 56 pharmaceuticals biopharmaceuticals 56 PER.C6 ® production 56 b Hib 56 candidate CRLX# 56 Fx #A 56 immunotherapeutics 56 micellar nanoparticle MNP 56 Panflu TM 56 Anthim 56 Phase 2a preventative 56 ASE SVA 56 multivalent vaccine 56 Acellular Pertussis Adsorbed 56 platinum chemotherapeutic 56 LGLS 56 INTEGRILIN R eptifibatide Injection 56 flu vaccine Fluarix 56 ritonavir boosted danoprevir 56 immunotherapeutic approaches 56 lyophilized formulation 56 CDAD Clostridium difficile 56 Supernus Pharmaceuticals 56 Crucell Announce 56 prevent invasive pneumococcal 56 Quinvaxem TM 56 Nanobody R 56 TNFerade TM 56 budesonide MMX Phase III 56 sublingual tablets 56 mesylate tablets approved 56 rALLy clinical trial 56 PSMA ADC 56 Currently RegeneRx 56 adrenergic regulation 56 Urocidin 55 ADVANCE PD 55 PER.C6 r 55 Qnexa TM 55 adjuvanted H#N# 55 muscarinic receptor agonist 55 Spiegelmer 55 Plicera 55 midstage trials 55 Relenza zanamivir 55 Influenza Vaccine 55 Afluria 55 UVIDEM 55 INOmax R 55 phase IIa 55 live attenuated influenza 55 Phase Ib clinical 55 ProCord 55 PGL# 55 phase Ib 55 Sinovac vaccine 55 PAION AG ISIN 55 metastatic sarcomas 55 IIa trial 55 EHT AGN 55 granulated mesalamine 55 NYSE Amex AEN 55 intranasal spray 55 cannabinor 55 Fluzone vaccine 55 TKM Ebola 55 IMVAMUNE R 55 intranasal vaccine 55 StemEx 55 Rotavirus vaccine 55 BEXXAR 55 Celtura 55 antigen sparing 55 proprietary VLP 55 #L Sterilizer 55 RenaZorb TM 55 product Zingo TM 55 prophylactic vaccine 55 Valortim TM 55 ACIP recommendation 55 Solazed 55 Amoxicillin PULSYS 55 Laevo 55 intranasal influenza vaccine 55 cMET inhibitor 55 NICOSAN ™ 55 investigational smallpox vaccine 55 oral treprostinil 55 RiVax ™ 55 Seasonal Influenza Vaccine 55 tremelimumab 55 equine osteoarthritis marketed 55 Phase IIIb clinical 55 RSD# oral 55 Ostabolin C TM 55 prepandemic 55 phase IIb trial 55 MorphoSys proprietary 55 Gentamicin Surgical Implant 55 ionotropic glutamate receptor antagonists 55 DEEP AF 55 Bioaccelerate compounds under 55 novel peptides 55 Phase III TRIST 55 Wafer polifeprosan 55 GALNS 55 BioSante Pharmaceuticals Announces 55 Aquinox 55 Glaxo cervical cancer 55 BLA filing 55 chickenpox varicella 55 Nasdaq MITI biopharmaceutical 55 dose escalation clinical 55 NTDDS 55 ChronVac C ® 55 recombinant insulin 55 ESTRASORB R 55 trastuzumab DM1 55 product platforms AZX# 55 small molecule PEGylation 55 Ceragenin 55 FACTIVE R gemifloxacin 55 pneumococcal conjugate vaccines 55 Cx# [002] 55 pertussis vaccines 55 TheraSphere R 55 EBx ® 55 GeoVax vaccine 55 Anflu 55 anticancer therapeutics 55 hepatitis B HBV 55 MAXY VII 55 MelaFind R 55 investigational medicinal 55 diphtheria tetanus pertussis polio 55 HTS assay 55 confirmatory clinical 55 antiviral oseltamivir 55 Nipent R 55 Tekmira lipid nanoparticle 55 Syncria albiglutide 55 REGEN trial 55 pneumococcal vaccines 55 Cellegesic TM nitroglycerin ointment 55 SuperAntibody 55 miglustat 55 Empatic ™ 55 Restanza TM 55 GlaxoSmithKline Biologicals GSK Biologicals 55 dermaceutical 55 recombinant antibodies 55 hyperphenylalaninemia HPA due 55 antibiotic telavancin 55 Evoltra TM 55 vero cell 55 PRESEPT study 55 Somatuline R Depot 55 DiabeCell ® 55 PTH1 55 StaphVAX 55 highly purified pasteurized 55 ketolide antibiotic 55 diphtheria tetanus pertussis 55 Rimantadine 55 Infanrix 55 technology visit http:/www.genmab.com 55 Tetanus diphtheria 55 adenovector 55 Pentacel 55 quadrivalent 55 Initiated Phase 55 Alvesco R 55 predictive toxicology 55 Peyronie disease Frozen Shoulder 54 proprietary capillary aerosolization 54 CholeraGarde R Peru 54 live attenuated intranasal 54 Hepatitis C Virus HCV 54 meningococcal vaccines 54 ADACEL vaccine 54 ACAM# 54 Albuferon Phase 54 neuraminidase inhibitor 54 RNAi therapeutic targeting 54 inhalation toxicology 54 SUMAVEL 54 rEV# 54 clinically differentiated 54 NeoVisc R 54 THALOMID 54 H#N# VLP 54 SUCCEED trial 54 contain thimerosal 54 Cerashield TM 54 novel immunotherapies 54 conserved antigens NP 54 FluMist nasal flu 54 HCD# [002] 54 clinical trials Archexin 54 ATryn ® GTC recombinant 54 ADVERSE EVENTS 54 FluLaval 54 phase IIb clinical 54 GTC recombinant form 54 FluBlok 54 subcutaneous PRO 54 cellular immunotherapy 54 Arepanrix 54 tetanus pertussis 54 nasal calcitonin product 54 Tetanus Diphtheria 54 multicenter Phase 54 AIMM trial 54 rotavirus shingles 54 buccal delivery 54 OncoVEX 54 Polysaccharide Diphtheria Toxoid Conjugate 54 agonistic human 54 Tegaserod 54 Flutiform ™ 54 human microdosing 54 Ixiaro 54 proprietary bioresorbable polymer 54 Hepatitis B vaccine 54 ENLIGHT 54 IV Busulfex 54 MVA MUC1 IL2 54 RSV prophylaxis 54 HBV vaccine 54 P#X# antagonist 54 Alfacell proprietary ribonuclease 54 plasmid DNA vaccine 54 Agriflu 54 Shire BioChem Inc. 54 R#/MEM 54 Alzhemed TM 54 Testosterone MDTS R 54 Ferinject ® 54 HuMax EGFr 54 Rhucin R 54 commercializing therapeutic 54 serine protease inhibitor CU# 54 double blinded placebo 54 inflammation hemophilia oncology 54 transmucosal delivery system 54 biocatalytic processes 54 Phase #b/#a trial 54 fusion enhancers 54 anticancer compound 54 Preotact R 54 Oseltamivir Tamiflu 54 FLUVIRIN vaccine 54 GetGoal Phase III 54 mg/m2 cohort 54 epoetin zeta 54 Phase Ib study 54 SIX RO ROG 54 Rhein Biotech GmbH 54 monovalent vaccine 54 liver resection surgeries 54 granted Ortec 54 Tetrabenazine 54 photodisinfection 54 cosmetic cosmeceutical products 54 proprietary radiolabeled monoclonal 54 Thelin tm 54 AEG# 54 EP #R 54 purified inactivated vaccine 54 ZOSTAVAX 54 Isolagen Process 54 bioengineered tissue 54 Crop BioScience 54 receptor tyrosine kinase inhibitor 54 Focetria 54 registrational trial 54 RenalGuard System TM 54 VitroGro 54 hepatitis B immunization 54 trivalent inactivated influenza 54 Prochieve R 54 antibiotic resistant bacterial infections 54 Sylvie Gregoire President 54 blinded randomized placebo controlled 54 AAV vector 54 LungAlert TM 54 Merck Suspends Lobbying 54 riociguat 54 bardoxolone 54 containing LABAs 54 TRISENOX R arsenic trioxide 54 Camvia 54 Evoltra R 54 preclinical toxicology 54 Neovasc Reducer 54 PEDIARIX 54 HP Acthar R 53 randomized controlled multicenter 53 intradermal vaccine 53 Hedgehog antagonist 53 Phase IIb III 53 Genz # 53 non adjuvanted vaccines 53 INOmax 53 nasal spray influenza 53 NO# [002] 53 ENTOCORT EC 53 multicenter randomized placebo controlled 53 Oasmia 53 rPA 53 5 lipoxygenase inhibitor 53 live attenuated vaccines 53 Vasogen Celacade TM 53 Phase 1a 53 tezampanel NGX# 53 Iomai vaccine 53 Ozarelix 53 Avoid jalapenos 53 therapeutics diagnostics 53 romazarit 53 HepaGam B TM 53 JOULFERON 53 Sinovac Dalian 53 Aphthasol R 53 DPOLT 53 tetanus diphtheria acellular pertussis 53 MSCRAMM R 53 zanamivir Relenza 53 influenza VLP vaccines 53 7 valent pneumococcal 53 overactive bladder AA# 53 inactivated flu 53 Loramyc ™ 53 Adsorbed 53 NEUMUNE 53 Provectus Pharmaceuticals specializes 53 randomized controlled Phase 53 GSK# [002] 53 Vaxfectin R 53 Phase 2b clinical trials 53 TFChem licenses 53 Levulan ® PDT 53 pandemic influenza vaccines 53 Clindesse TM 53 vivo glucose 53 Unigene nasal calcitonin 53 Vaxfectin formulated 53 MAA submission 53 Invasive pneumococcal disease 53 PREOS R 53 CRD5 53 generation rotary VAD 53 optimal dosing regimens 53 SGLT Inhibitors 53 Mipomersen 53 patented DepoVax ™ 53 VLP vaccines 53 Luramist 53 Erimos 53 ESTRASORB 53 recombinant FVIII 53 diagnostics therapeutics 53 antibiotics antivirals 53 commercializing anti infective 53 fluorinated carbohydrate mimics 53 Pediarix 53 Intanza 53 commercialize dutogliptin 53 PREFLUCEL 53 Hib vaccines 53 pentavalent vaccine 53 MBX TSX 53 MSCRAMM ® 53 pneumococcal conjugate vaccine 53 rotavirus vaccines 53 rotary VAD 53 developing TB4 53 PFO migraine 53 Optaflu 53 QuickVue R 53 DAC HYP 53 Gammagard Liquid 53 Nobilon 53 mSEPT9 biomarker 53 IoGen ™ 53 NYSE Amex NBY clinical 53 HIN1 53 Wyeth Prevnar 53 diagnostic radiopharmaceutical 53 hyaluronidase rHuPH# 53 trodusquemine MSI 53 Tdap tetanus diphtheria pertussis 53 EXPLORE Xa 53 Dukoral ® 53 GVAX cancer 53 blockers angiogenesis inhibitors 53 phase IIb 53 BENLYSTA ™ 53 budesonide foam 53 IND enabling 53 registrational 53 IIb clinical trial 53 treat GI GVHD 53 pharmaceuticals biologics 53 Phase Ib IIa clinical 53 Enbrel rheumatoid arthritis 53 antiviral therapeutics 53 recombinant plasma 53 Oncotype DX colon cancer 53 unadjuvanted vaccines 53 tetanus polio 53 protein biochip 53 implantable glucose 53 trivalent oral 53 toxoid 53 Dyax phage display 53 TRANSDUR ™ 53 rThrombin 53 Ipsen Euronext IPN 53 neuro inflammatory disorders 53 subcutaneous methylnaltrexone 53 approved incretin mimetic 53 HCV protease inhibitors 53 inactivated poliovirus vaccine 53 inactivated poliovirus 53 initiate Phase IIb 53 peptide therapeutics 53 siRNA therapeutics 53 targeted radiotherapeutics 53 Oncaspar 53 Econiche 53 EGS# 53 DGAT1 inhibitors 53 ADAGEN 53 PRECISE Trial 53 autologous dendritic cell 52 lorvotuzumab mertansine 52 purified inactivated 52 fatty acid amide hydrolase 52 Thiakis 52 custom peptide synthesis 52 rindopepimut 52 IMC #B 52 Pneumococcal Conjugate Vaccine 52 simplex virus 52 AutovaxID 52 quadrivalent vaccine 52 acellular pertussis DTaP 52 hyperimmune products 52 Merck Serono discovers develops 52 Anticalins R 52 monovalent 52 biocompatible coatings 52 PROSTASCINT R 52 Phase 1b clinical 52 PROCHIEVE ® 52 Vaxigrip 52 Vaccine Diphtheria CRM# Protein 52 Somatuline Depot 52 Td vaccine 52 therapeutic peptide 52 diphtheria toxoid 52 poliovirus vaccine 52 proprietary BiTE ® 52 Phase III registrational 52 DNA plasmids 52 thorough QT 52 monoclonal antibody therapeutics 52 Taligen Therapeutics 52 diphtheria pertussis 52 commercialize omacetaxine 52 PER.C6 ® cell 52 Influvac 52 Virosome Biologicals 52 Lofexidine 52 Phase Ib clinical trials 52 therapeutic radiopharmaceuticals 52 Plasma Converter TM 52 research anddevelopment 52 staphylococcal vaccines 52 MF# adjuvanted 52 Adherex Technologies 52 TransMID 52 Acetavance TM 52 Begin Clinical Trials 52 pharmacological chaperone 52 Pneumococcus 52 Tamiflu Relenza 52 SparVax TM 52 adjuvanted vaccines 52 polyclonal antibody 52 Phase IIIb 52 Influenza Virus Vaccine 52 Comvax 52 TIMERx 52 Swine flu vaccines 52 UMN Pharma 52 BUPHENYL R 52 NeutroSpec TM 52 Phase Ia 52 Oral Polio Vaccine 52 velaglucerase alfa 52 Campto 52 pharmaceutically relevant 52 Gonal f R 52 nasal spray vaccines 52 manufacturing interventional vascular 52 daptomycin 52 Fluzone Intradermal vaccine 52 shingles vaccine Zostavax 52 OPi 52 pandemic influenza vaccine 52 assessing T DM1 52 MEND CABG II 52 Rotavirus causes 52 Unifill 52 topically delivered 52 anthrax botulism typhoid 52 ZaBeCor 52 Urocidin TM 52 PentaLyte 52 therapeutic monoclonal antibodies 52 Intas Biopharmaceuticals 52 HPV Human Papillomavirus 52 monovalent vaccines 52 novel antibody therapeutics 52 Varivax 52 Aloprim TM allopurinol sodium 52 MF# adjuvant 52 metabonomics 52 ELADUR ™ 52 Phase #/#a clinical 52 Gynazole 1 52 Adenosine Therapeutics 52 Profectus BioSciences 52 PANFLU.1 52 VALOR trial 52 H#N# influenza vaccine 52 NOX E# 52 Quinvaxem ® 52 NexVas TM 52 Human papillomavirus HPV 52 streptococcal vaccine 52 bOPV 52 haemophilus influenza B 52 prophylactic vaccines 52 SoluBest 52 isavuconazole 52 proprietary GelSite R 52 trivalent vaccine 52 EMPOWER ™ 52 rheumatoid arthritis thrombocytopenia 52 ACIP recommends 52 developing Surfactant Therapies 52 AQUA ® 52 MIST II 52 MMRV vaccine 52 carbohydrate polymers 52 Truvada emtricitabine 52 VICTOR E1 52 intranasal mist 52 Vaxfectin R adjuvant 52 Skin Cholesterol Test 52 HPAPIs 52 Ibis T# TM 52 Oncosphere System 52 class PDE5 inhibitor 52 opioid bowel dysfunction 52 Nanobodies ® 52 infant formulas containing 52 Sevelamer 52 ThGRF 52 Chromax chromium picolinate 52 PPSV# 52 vaccine Menactra 52 Conjugate Vaccine 52 placebo controlled Phase III 51 meningococcal conjugate vaccine 51 registrational Phase 51 LUX Lung 51 virology Progenics 51 Ebola vaccine 51 Biopump 51 Evoclin R 51 disposable bioprocessing 51 ZALBIN 51 GeoVax AIDS vaccine 51 injectible vaccine 51 maturation inhibitor 51 Second Pivotal Phase 51 proprietary biomaterials 51 retaspimycin 51 A/H#N# flu vaccines 51 biotherapies 51 Phase IIa trials 51 Phase 1b clinical trials 51 pharmaceuticals nutraceuticals 51 ERYtech 51 reemerging infectious diseases 51 Glufast 51 Boostrix 51 AeroLEF TM 51 Prevenar 51 HRIG 51 small volume parenterals 51 Crucell PER.C6 51 calcium phosphate nanotechnology CaP 51 acellular pertussis 51 laninamivir 51 human antibody therapeutics 51 silver dihydrogen citrate 51 BioThrax ® Anthrax Vaccine 51 Phage Pharmaceuticals 51 autoimmune cardiovascular 51 myasthenia gravis Huntington